-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$22.75253.81% Upside
Biomea Fusion, Inc. Frequently Asked Questions
-
What analysts cover Biomea Fusion, Inc.?
Biomea Fusion, Inc. has been rated by research analysts at Piper Sandler, Barclays, H.C. Wainwright, Scotiabank in the past 90 days.